Oct 14, 2016
Amgen Announces Top-Line Results from Phase 3 KYPROLIS® (Carfilzomib) CLARION Study in Patients with Newly Diagnosed Multiple Myeloma Sept. 27, 2016

seen from United States
seen from United States

seen from Netherlands

seen from United States

seen from Germany
seen from United States

seen from United States

seen from United States
seen from United States

seen from Norway

seen from Norway
seen from Maldives
seen from Yemen

seen from United States
seen from Italy

seen from Germany
seen from United States
seen from Germany

seen from Germany
seen from United States
Amgen Announces Top-Line Results from Phase 3 KYPROLIS® (Carfilzomib) CLARION Study in Patients with Newly Diagnosed Multiple Myeloma Sept. 27, 2016